Set against the backdrop of human migration and population admixture, Turkey is known for a genetically diverse population at the crossroads of Europe and Asia. Today, with close to 41 genetic centers spread across its 81 cities, the country has been rapidly emerging as a critical hub for medical genomics.

At the center of this stands Prof. Serdar Ceylaner, leading medical geneticist and founder of the Intergen Center for Genetics and Rare Diseases Diagnosis, whose work in rare and undiagnosed diseases has not only been steering significant advancements in the understanding of these conditions, but also opening doors to personalized care and improved patient quality of life.

As we celebrate World Cancer Day, we’re spotlighting the transformative impact of genomics in precision medicine for oncology. The theme of World Cancer Day 2025 is “United by Uniquel”, today in the latest episode of the MGI podcast, we invite industry experts shared their insights on the evolving landscape of genomic medicine, and multiple collaborative entities unite in their mission to conquer cancers—

• Dr Cheng Boon – Oncologist and OncoDNA UK Medical Director, shares frontline clinical insights
• Dr Gareth Gerrard – Clinical Scientist and Scientific Lead for Cancer at the South East Genomics Laboratory Hub, London, discusses the challenges and opportunities in implementation.
• Filips Oleskovs – Business Development at MGI Tech, representing the technology provider's perspective, highlighted the innovations driving broader accessibility.